detect a difference between cranberry juice and placebo. In the Methods, the authors state that their sample size calculations were based on an anticipated UTI recurrence rate of 30%. However, the actual observed rate in the placebo arm was only 14%. Therefore, adequate power would have required enrollment of 656 participants, which we realize is a challenging task.
Other populations of women may benefit from daily cranberry juice or pills. Barbosa-Cesnik et al [1] present interesting data suggesting no benefit to cranberry juice in patients with a history of 2 UTIs. These findings conflict with other trials that have shown beneficial effects with cranberry juice for women with 2 UTIs, including a Cochrane review, which showed significant reduction in the number of recurrent UTIs with daily cranberry use in select patient populations [2] -findings that were driven by clinical trials of women who have a history of 3 UTIs in the past year [3] [4] [5] . Effective prevention strategies for recurrent UTIs may only work in populations of women at higher risk for recurrence.
